… The right of author Robert A. Copeland to be identified as the author of this work has been
… I thank June Davis, Petra Marchand, Diane Lombardo, Robert Lombardo, John Giannaras, …

The drug–target residence time model was first introduced in 2006 and has been broadly
adopted across the chemical biology, biotechnology and pharmaceutical communities. While …

… Evalaution of Enzyme Inhibitors in Drug Discovery by Robert A. Copeland has been an
invaluable guide to the community of scientists devoted to finding new drugs in all therapeutic …

Much of drug discovery today is predicated on the concept of selective targeting of particular
bioactive macromolecules by low-molecular-mass drugs. The binding of drugs to their …

Selective inhibition of the inducible isoform of prostaglandin G/H synthase (cyclooxygenase-2;
COX2; EC 1.14.99.1) can be achieved with compounds of the general form of aryl methyl …

The formation and duration of binary receptor−ligand complexes are fundamental to many
physiologic processes. Most often, the effectiveness of interaction between a receptor and its …

EZH2, the catalytic subunit of the PRC2 complex, catalyzes the mono- through trimethylation
of lysine 27 on histone H3 (H3K27). Histone H3K27 trimethylation is a mechanism for …

The compound U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio]butadiene) was
identified as an inhibitor of AP-1 transactivation in a cell-based reporter assay. U0126 was …

With the revolution that has occurred in Molecular Biology over the past twenty years, an
exponential growth has occurred in the number of laboratories and researchers that now find …

Although drug–target interactions are commonly illustrated in terms of structurally static
binding and dissociation events, such descriptions are inadequate to explain the impact of …